The non-ligand binding β-isoform of the human glucocorticoid receptor (hGRβ): Tissue levels, mechanism of action, and potential physiologic role

Molecular Medicine

Volumn 2, Issue 5, 1996, Pages 597-607

  De Castro, Margaret ^a   Elliot, Sharon ^a   Kino, Tomoshige ^a   Bamberger, Christoph ^a   Karl, Michael ^a   Webster, Elizabeth ^a   Chrousos, George P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR;

ALTERNATIVE RNA SPLICING; ANTIBODY SPECIFICITY; ARTICLE; CHROMOSOME 5; DIMERIZATION; DRUG RECEPTOR BINDING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LIGAND BINDING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TISSUE LEVEL;

EID: 0029807036     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401643     Document Type: Article

References (35)

1. Hollenberg SM, Weinberger C, Ong ES, et al. (1985) Primary structure and expression of functional human glucocorticoid receptor cDNA. Nature 318: 635-641.
2. Encio IJ, Detera-Wadleigh SD. (1991) The genomic structure of the human glucocorticoid receptor. J. Biol. Chem. 266: 7182-7188.
3. Giguere V, Hollenberg SM, Rosenfeld MG, Evans RM. (1986) Functional domains of human glucocorticoid receptor. Cell 46: 645-652.
4. Hurley DM, Accili D, Stratakis CA, et al. (1991) Point mutation causing a single amino acid substitution in the hormone-binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J. Clin. Invest. 87: 680-686.
5. Karl M, Lamberts SWJ, Detera-Wadleigh SD, et al. (1993) Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J. Clin. Endocrinol. Metab. 76: 683-689.
6. Chrousos GP, Detera-Wadleigh SD, Karl M. (1993) Syndromes of glucocorticoid resistance. Ann. Intern. Med. 119: 1113-1124.
7. Bamberger CM, Bamberger A-M, Castro M, Chrousos GP. (1995) Glucocorticoid receptor-β, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95: 2435-2441.
8. Oakley RH, Sar M, Cidlowski JA. (1996) The human glucocorticoid receptor β isoform. J. Biol. Chem. 271: 9550-9559.
9. Yamamoto KR. (1985) Steroid receptor regulated transcription of specific genes and gene networks. Annu. Rev. Genet. 19: 209-252.
10. Picard D, Yamamoto KR. (1987) Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 6: 3333-3340.
11. Evans RM. (1988) The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
12. Picard D, Salserand JS, Yamamoto KR. (1988) A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell 54: 1073-1080.
13. Truss M, Beato M. (1993) Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors. Endocr. Rev. 14: 459-479.
14. Kaumaya PTP, Berndt KDA, Heidorn DB, Ttrewhella J, Kezdy FJ, Goldberg E. (1990) Synthesis and biophysical characterization of engineered topograph immunogenic determinant with α α topology. Biochemistry 29: 13-23.
15. Ulrich SM, Moore SK, Appella E, May P. (1989) Transcriptional and translation analysis of the murine 84- and 86-KDa heat shock proteins. J. Biol. Chem. 264: 6810-6816.
16. 4. Nature 227: 680-685.
17. Elliot S, Goldsmith P, Knepper M, Haughey M, Olson B. (1996) Urinary excretion of aquaporin-2 in humans: a potential marker of collecting duct responsiveness to vasopressin. J. Am. Soc. Nephrol. 7: 403-409.
18. Tomita M, Chrousos GP, Brandon DD, et al. (1985) Glucocorticoid receptors in EpsteinBarr virus-transformed human lymphocytes. Horm. Metabol. Res. 17: 674-678.
19. Karl M, Steven SWJ, Koper JW, et al. (in press) Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. PAAP. 108: 296-307.
20. Wang Y, Micsicek RJ. (1991) Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol. 5: 1707-1715.
21. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW. (1993) Human progesterone A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol. 7: 1244-1255.
22. Katz D, Lazar MA. (1993) Dominant negative activity of an endogenous thyroid hormone receptor variant (α2) is due to competition for binding sites on target genes. J. Biol. Chem. 268: 20904-20910.
23. Nagaya T, Jameson JL. (1993) Thyroid hormone resistance syndrome: Correlation of dominant negative activity and location of mutations. J. Clin. Endocrinol. Metab. 77: 982-990.
24. Cooney AJ, Leng X, Tsai Si, Tsai M-J, O'Malley BW. (1993) Multiple mechanism of chicken ovalbumm upstream promotor transcription factor-dependent repression of transactivation by the vitamin D, thyroid hormone, and the retinoic acid receptors. J. Biol. Chem. 268: 4252-4160.
25. Liu R-T, Suzuki S, Miyamoto T, Takeda T, Ozata M, DeGroot LJ. (1995) The dominant negative effect of thyroid receptor splicing variant α2 does not require binding to a thyroid response element. Mol. Endocrinol. 9: 86-95.
26. Pratt WB. (1993) The role of heat shock protein in regulating the function, folding, and trafficking of the glucocorticoid receptor. J. Biol. Chem. 268: 21455-21458.
27. Pratt WB, Sanches ER, Bresnick EH, et al. (1989) Interaction of the glucocorticoid receptor with the MW 90,000 heat shock protein: An envolving model of ligand-mediated transformation and translocation. Cancer Res. 49: 2222-2229.
28. Dalman CF, Scherrer CL, Taylors PL, Akil H, Pratt WB. (1991) Localization of the 90-kDa heat shock protein-binding site within the hormone-binding domain of the glucocorticoid receptor by peptide competition. J. Biol. Chem. 266: 3482-3490.
29. Tsai M-J, O'Malley BW. (1994) Molecular mechanism of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63: 451-479.
30. Smith DF. (1993) Dynamics of heat shock protein 90-progesterone receptor binding and the disactivation loop model for steroid receptor complexes. Mol. Endocrinol. 7: 1418-1429.
31. Tilders FJ, DeRijk RH, Van Damm AM, Vincent VA, Schotanus K, Persoons JH. (1994) Activation of the hypothalamic-pituitary-adrenal axis by bacterial endotoxins: Routes and intermediate signals. Psychoneuroendocrinology 19: 209-232.
32. Chrousos GP. (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332: 1351-1362.
33. Chrousos GP, Castro M, Leung DY, et al. (in press) Molecular mechanisms of glucocorticoid resistance/hypersensitivity: Potential clinical implications. Am. J. Respir. Crit. Care Med.
34. Sher ER, Leung DY, Surs W, et al. (1994) Steroid-resistant asthma. Cellular mechanisms contributing to inadequate responses to glucocorticoid therapy. J. Clin. Invest. 93: 33-39.
35. Castro M, Leung DY, Karl M, et al. (1996) Changes in the alternative splicing of the glucocorticoid receptor gene might contribute to the pathogenesis of glucocorticoid-resistant asthma. Program of the 10th International Congress of Endocrinology, San Francisco. Abstract.